Providing the tool for targeted therapy. A New Standard for Rapid Biological Testing. BioSense Technologies has developed a new rapid method for determining the physiological status of cells. The company is using this technology to determine the effectiveness of therapeutic agents on eukaryotic and prokaryotic cells in real-time. Our goal is to improve the diagnosis and treatment of cancer and infectious diseases by identifying drug resistance for the administration of targeted therapies.

Our research team includes biomedical-electrical professor, engineers and physician with the mission of designing new micro-electronic sensors and home care instruments for the advancement of healthcare for mankind. The engineering group comprises of researchers from Miami, USA and Taipei, Taiwan who have been working in collaborati.

This site is published by Biosense Webster, Inc. which is solely responsible for its content.

Le développement durable du capital humain. Afin de pouvoir utiliser pleinement son potentiel Humain avec les autres.

Your versatile solution for multiplex diagnosis. RapiPlex is a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. For research only currently not approved for clinical use.